http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2364867-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10efc646a4dd605c2f09c493718f5b81 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 |
| filingDate | 2008-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d36328e4bddd3dbe1806a763a622c04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09fdfb94b20902f8e821416f5699e29e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_159399336d780716a35742169af31b4f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58e033a3264cf1448175d9621d385561 |
| publicationDate | 2009-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2364867-C1 |
| titleOfInvention | Method for analysis of nonneoplastic obstructive jaundice severity |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely to surgery and can be used in surgery, resuscitation, and clinical immunology. The method for analysis of nonneoplastic obstructive jaundice severity is ensured by detailed blood test to evaluate the indices: leukocytic intoxication index by Calf-Caliph (LII1), leukocytic intoxication index by Ostrovsky (LII2), stress index (SI), segmented neutrophil to lymphocyte ratio index (LRI), neutrophil to lymphocyte ratio index (NLRI) and lymphocyte to eosinophil ratio index (LERI). Provided LII1≤2.5, LII2≤2.75, SI≤1.0, LRI≤7.0, NLRI≤12.0, LERI≤18.0, severity is estimated as mild. If LII1 is within 2.6 to 4.5, LII2 is within 2.76 to 5.0, SI is within 1.1 to 2.0, LRI is 7.1 to 10.0, NLRI is 12.1 to 16.0, LERI is within 18.1 to 22.0, and then moderate severity is determined. While LII1 exceeds 4.5, LII2 is more than 5.0, SI is more than 2.0, LRI exceeds 10.0, NLRI goes beyond 16.0 and LERI is more than 22.0, severe pathological process is observed. Application of the invention allows for objective and rapid analysis of pathological process severity to prescribe intensified antibacterial and detoxification therapy for severe cases. n EFFECT: enabled objective and rapid analysis of pathological process severity to prescribe intensified antibacterial and detoxification therapy for severe cases. n 2 tbl, 3 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2677468-C1 |
| priorityDate | 2008-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.